Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment

This article will consider the perspectives of different stakeholders (patients, health care payers, health care professionals, and manufacturers) on the provision of a research-enabled, patient-focused molecular diagnostics platform that supports optimal patient care. Through the discussion of specific case studies, and building on the experience from countries that have successfully integrated molecular diagnostics into clinical practice, this article will discuss the necessary evolutions in policy and health technology assessment to ensure that patients can have equal access to appropriate molecular diagnostics.Public Health Genomics 2016;19:144-152
Source: Public Health Genomics - Category: Genetics & Stem Cells Source Type: research